TipRanks on MSN
Aldeyra Therapeutics completes promising phase 2 trial for alcohol-associated hepatitis
Aldeyra Therapeutics ($ALDX) announced an update on their ongoing clinical study. Study Overview: Aldeyra Therapeutics recently completed a Phase ...
In 2023, 48.5 million Americans over the age of 12 (or 16.7%) suffered from a substance use disorder in the past year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback